Circulating cell-free tumor DNA (ctDNA) can serve as a real-time biomarker of tumor burden
and provide unique insights into the evolving molecular landscape of cancers under the …

Genomic medicine attempts to build individualized strategies for diagnostic or therapeutic
decision-making by utilizing patients' genomic information. Big Data analytics uncovers …

Technologies in genomic medicine have rapidly evolved and transformed the ability to
deliver precision medicine in nearly every field of health care. As genomic medicine has …

Next-generation sequencing (NGS) is rapidly expanding into routine oncology practice.
Genetic variations in both the cancer and inherited genomes are informative for hereditary …

Purpose Integrating genomic data into the electronic health record (EHR) is key for optimally
delivering genomic medicine. Methods The PennChart Genomics Initiative (PGI) at the …

The use of genomics in medicine is expanding rapidly, but information systems are lagging
in their ability to support genomic workflows both from the laboratory and patient-facing …

PURPOSE Next-generation sequencing (NGS) of tumor and germline DNA is foundational
for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic …

Electronic medical records (EMRs) were primarily introduced as a digital health tool in
hospitals to improve patient care, but over the past decade, research works have …

Introduction Thanks to improvement of care, cancer has become a chronic condition. But
due to the toxicity of treatment, the importance of supporting the quality of life (QoL) of cancer …

PURPOSE Oncologists are increasingly using molecular profiling to inform personalized
patient treatment decisions. Despite its promising utility, the integration of genomic testing …